264 related articles for article (PubMed ID: 7690275)
1. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.
Okada K; Kim YI; Nakashima K; Tada I; Yoshida T; Kobayashi M; Yokoyama S
Surg Today; 1993; 23(7):626-31. PubMed ID: 7690275
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
Okano A; Hajiro K; Takakuwa H; Kobashi Y
Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Sato K; Tanaka M; Kusaba T; Fukuda H; Tanikawa K
Oncol Rep; 1998; 5(2):355-8. PubMed ID: 9468556
[TBL] [Abstract][Full Text] [Related]
4. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
5. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type].
Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A
Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156
[TBL] [Abstract][Full Text] [Related]
6. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma.
Matsuyama M; Yamazaki O; Horii K; Higaki I; Kawai S; Mikami S; Higashino M; Oka H; Nakai T; Inoue T
J Surg Oncol; 2000 Nov; 75(3):197-202. PubMed ID: 11088052
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
[TBL] [Abstract][Full Text] [Related]
8. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Zheng Y; Zhu M; Li M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
[TBL] [Abstract][Full Text] [Related]
10. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
11. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
12. Serum sphingosine negatively correlates with albumin predicting the risk of hepatocellular carcinoma.
Huang K; Li W; Xiao J; Luo D; Jin J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):203-208. PubMed ID: 31074463
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Chang YC; Dai YC; Chow NH
Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
15. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
Wu C; Bai DS; Jiang GQ; Jin SJ
World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.
Izumi R; Shimizu K; Kiriyama M; Hashimoto T; Urade M; Yagi M; Mizukami Y; Nonomura A; Miyazaki I
J Surg Oncol; 1992 Mar; 49(3):151-5. PubMed ID: 1372375
[TBL] [Abstract][Full Text] [Related]
17. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.
Görög D; Regöly-Mérei J; Paku S; Kopper L; Nagy P
World J Gastroenterol; 2005 Aug; 11(32):5015-8. PubMed ID: 16124056
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
